Search clinical trials for: fingolimob (FTY)
Total 474 results
-
Novartis PharmaceuticalsTerminatedAcute Demylelinating Optic NeuritisUnited States, Spain
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPain | Chemotherapy-Induced Peripheral Neuropathy | Numbness | TinglingUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CarcinomaUnited States
-
Jordan Collaborating Cardiology GroupRecruiting
-
Novartis PharmaceuticalsCompletedKidney TransplantationUnited States
-
Centre Hospitalier Universitaire, AmiensUnknownHIV Infections | ThyroidFrance
-
University Hospital, Basel, SwitzerlandNovartisCompletedRett's SyndromeSwitzerland
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Novartis PharmaceuticalsWithdrawnMultiple Sclerosis (Relapsing Remitting)
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
University Hospital, CaenRecruitingMultiple SclerosisFrance
-
Medical University of GdanskCompletedSecondary HypothyroidismPoland
-
Asofarma S.A.I. y C.Zenith Technology Corporation LimitedCompletedHealthy VolunteersNew Zealand
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Argentina, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
NovartisCompletedRenal InsufficiencyRussian Federation
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Heinrich-Heine University, DuesseldorfNovartis PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing-RemittingTurkey
-
Tianjin Medical University General HospitalCompletedStroke | Stroke, Acute | Cerebral Stroke | Ischemic Cerebrovascular Accident | Vascular AccidentChina
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Novartis PharmaceuticalsCompletedMultiple SclerosisItaly, Belgium, Germany
-
Ning Wang, MD., PhD.Recruiting
-
Novartis PharmaceuticalsRecruiting
-
Tang-Du HospitalNot yet recruitingIntracerebral Hemorrhage
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisDenmark, Spain, Switzerland, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Cyprus, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Mexico, Netherlands, Norway, Poland, ... and more
-
Novartis PharmaceuticalsCompleted
-
Craig HospitalNational Institute on Disability, Independent Living, and Rehabilitation...Enrolling by invitationCervical Spinal Cord InjuryUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedGlioblastoma | Anaplastic AstrocytomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital and other collaboratorsWithdrawnStroke | InflammationChina
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisGermany, South Africa, Italy, United States, Austria, Belgium, Czechia, Egypt, Hungary, Malaysia, Turkey, Spain, Australia, Canada, France, Israel, Netherlands, Switzerland, Greece, Korea, Republic of, Romania, Russian Federation, United... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis RRMSGermany, Switzerland
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
NovartisCompletedMultiple SclerosisUnited States, Canada
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
Novartis PharmaceuticalsCompletedMultiple SclerosisUnited States, Australia, Canada, Mexico, Argentina, Puerto Rico, Chile
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisUnited States
-
First Affiliated Hospital of Fujian Medical UniversityWithdrawn
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminated
-
Massachusetts General HospitalALS Therapy Development InstituteCompleted
-
General Hospital of Shenyang Military RegionRecruiting
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital and other collaboratorsRecruitingStroke | InflammationChina
-
Hikma Pharmaceuticals LLCActive, not recruitingRelapsing-Remitting Multiple SclerosisEgypt
-
The Affiliated Hospital of Xuzhou Medical UniversityUnknown
-
McGill UniversityNovartisCompletedMultiple Sclerosis-Relapsing-RemittingCanada
-
NovartisMitsubishi Tanabe Pharma CorporationCompleted
-
Novartis PharmaceuticalsMitsubishi Tanabe Pharma CorporationCompletedChronic Inflammatory Demyelinating PolyradiculoneuropathySpain, United States, Belgium, Germany, Italy, Israel, Australia, France, United Kingdom, Netherlands, Czechia, Japan, Canada, Greece, Poland